Janssen, LP clinical trials
A subsidiary of Johnson & Johnson
The registry lists 31 studies whose lead sponsor is Janssen, LP. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 27, 2025.
Registry sponsor names on this page
- Janssen, LP20 studies
- Janssen Inc.11 studies
Something wrong with this grouping? Tell us on the Johnson & Johnson page.
Studies
Recruiting first, then most recently updated. Showing 31 of 31. All Johnson & Johnson studies →
- Biologic Treatment Registry Across CanadaCompletedNCT00741793
Sponsor listed in the registry: Janssen Inc.
- Golimumab for Adherence in Rheumatoid ArthritisCompletedNCT03729349
Sponsor listed in the registry: Janssen Inc.
- A Study of Participants With Advanced Prostate Cancer in CanadaCompletedNCT03501173
Sponsor listed in the registry: Janssen Inc.
- A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology SettingCompletedNCT02364531
Sponsor listed in the registry: Janssen Inc.
- An Observational Study to Assess the Canagliflozin Treatment in Type 2 Diabetes Mellitus in a Usual Clinical Practice in CanadaCompletedNCT02688075
Sponsor listed in the registry: Janssen Inc.
- A Study to Evaluate CNTO 1959 in the Treatment of Patients With Moderate to Severe Plaque-type PsoriasisCompletedNCT01483599Phase 2
Sponsor listed in the registry: Janssen Inc.
- Observational Study of Golimumab Intravenous InfusionTerminatedNCT02390700
Sponsor listed in the registry: Janssen Inc.
- An Observational Study of Case Managed Versus Non-case Managed Initiation of HemodialysisCompletedNCT01613404
Sponsor listed in the registry: Janssen Inc.
- An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected PatientsCompletedNCT01615601
Sponsor listed in the registry: Janssen Inc.
- Observational Study in Patients With Schizophrenia Treated With Long-Acting Risperidone Injection (RISPERDAL CONSTA)CompletedNCT00246194
Sponsor listed in the registry: Janssen, LP
- The Efficacy of Open Label Infliximab for the Induction and Maintenance of Mucosal Healing in Small Bowel Crohn's Disease Assessed Through Wireless Camera EndoscopyCompletedNCT01181765Phase 4
Sponsor listed in the registry: Janssen Inc.
- Remicade Infusion Management ProgramCompletedNCT00723905
Sponsor listed in the registry: Janssen Inc.
- A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderCompletedNCT00253110Phase 4
Sponsor listed in the registry: Janssen, LP
- A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.CompletedNCT00261430Phase 4
Sponsor listed in the registry: Janssen, LP
- A Long-term Safety Study for Long-acting Injectable Risperidone in Schizophrenia or Schizoaffective Disorder Patients.CompletedNCT00495118Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00236379Phase 4
Sponsor listed in the registry: Janssen, LP
- Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective DisorderCompletedNCT00236353Phase 3
Sponsor listed in the registry: Janssen, LP
- A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.CompletedNCT00558298Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol in Patients With Chronic SchizophreniaCompletedNCT00249119Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaCompletedNCT00249132Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With DementiaCompletedNCT00253123Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study of the Effectiveness and Safety of Long-acting Injectable Risperidone Versus Placebo in the Treatment of Patients With SchizophreniaCompletedNCT00253136Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.CompletedNCT00378183Phase 4
Sponsor listed in the registry: Janssen, LP
- Protocol For the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433)CompletedNCT00002027Not applicable
Sponsor listed in the registry: Janssen, LP
- Evaluation of Galantamine in the Treatment of Alzheimer's DiseaseCompletedNCT00000172Phase 3
Sponsor listed in the registry: Janssen, LP
- A Study of Treatments for Fungal Infections of the Mouth and Throat in HIV-Infected Patients Who Have Had Success With Itraconazole But Not With FluconazoleCompletedNCT00002341Not applicable
Sponsor listed in the registry: Janssen, LP
- A Study of Itraconazole in the Prevention of Histoplasmosis, a Fungal Infection, in HIV-Infected PatientsCompletedNCT00002438Not applicable
Sponsor listed in the registry: Janssen, LP
- A Randomized, Open, Comparative Multicenter Study of Initial Treatment With Intravenous Itraconazole Versus Amphotericin B Followed by Consolidation Treatment With Itraconazole Capsules in Patients With Blastomycosis or HistoplasmosisCompletedNCT00002159Phase 3
Sponsor listed in the registry: Janssen, LP
- Study of Itraconazole in Patients With Advanced HIV InfectionCompletedNCT00002370Not applicable
Sponsor listed in the registry: Janssen, LP
- A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDSCompletedNCT00002278Not applicable
Sponsor listed in the registry: Janssen, LP
- An Open Study of the Effect of Itraconazole Oral Solution for the Treatment of Fluconazole Refractory Oropharyngeal Candidiasis in HIV-Positive Subjects.CompletedNCT00002133Not applicable
Sponsor listed in the registry: Janssen, LP